Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-006807

Chair and CEO sold 25,580 shares at an average $81.03 ($2,072,721)

  • Chair and CEO acquired 25,580 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lewis William Chair and CEO 2025-02-18 Option exercise 10b5-1 +18,750 $22.76 $426,750 352,936 D: show line 1 in the form
Lewis William Chair and CEO 2025-02-18 Sale 10b5-1 −1,253 $79.95 $100,177 351,683 D: show line 2 in the form
Lewis William Chair and CEO 2025-02-18 Sale 10b5-1 −16,743 $81.08 $1,357,522 334,940 D: show line 3 in the form
Lewis William Chair and CEO 2025-02-18 Sale 10b5-1 −754 $81.67 $61,579 334,186 D: show line 4 in the form
Lewis William Chair and CEO 2025-02-18 Option exercise 10b5-1 +6,830 $10.85 $74,106 240,754 I: show line 5 in the form
Lewis William Chair and CEO 2025-02-18 Sale 10b5-1 −456 $80.00 $36,480 240,298 I: show line 6 in the form
Lewis William Chair and CEO 2025-02-18 Sale 10b5-1 −6,074 $81.07 $492,419 234,224 I: show line 7 in the form
Lewis William Chair and CEO 2025-02-18 Sale 10b5-1 −300 $81.81 $24,543 233,924 I: show line 8 in the form
Open-market sales · 25,580 sh · avg $81.03 · $2,072,721

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lewis William Chair and CEO 2025-02-18 Option exercise · Stock Option (right to buy) 10b5-1 −18,750 37,500 D: show line 9 in the form
Lewis William Chair and CEO 2025-02-18 Option exercise · Stock Option (right to buy) 10b5-1 −6,830 204,970 I: show line 10 in the form
Loading xslF345X05/wk-form4_1740088354.xml…